Meningococcal group A, C, W 135 and Y conjugate vaccine (Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal group A, C, W 135 and Y conjugate vaccine (Pfizer)
Drug Alias Name脑膜炎球菌A，C，W 135-Y结合疫苗NimenrixGSK 134612
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Biological material > Toxoid vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2012/04/20
Country/TerritoryCzechiaCanadaPanama +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncSanofi PasteurPfizer Europe Ma Eeig
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH08
Related LinksWikipediaKEGG